ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Bumble, Panera Bread, CrunchBase, Match Hit by Cyberattacks 
Owner of Assisted Living Home Where 10 Died in Fire Denied Access to Insurance Funds 
Florida Board Drafting Rules That Could Stem Bogus Engineering Reports in Claims 
Navigators Can’t Parse ‘Additional Insured’ Policy Wording in Georgia Explosion Case From This Issue
